MacroGenics
MGNX
#9001
Rank
A$0.17 B
Marketcap
A$2.77
Share price
-1.51%
Change (1 day)
-24.47%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: A$0.17 Billion

As of March 2026 MacroGenics has a market cap of A$0.17 Billion. This makes MacroGenics the world's 9001th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.17 B15.18%
2025A$0.15 B-53.35%
2024A$0.32 B-62.79%
2023A$0.87 B44.49%
2022A$0.60 B-55.34%
2021A$1.35 B-18.83%
2020A$1.67 B

End of Day market cap according to different sources

On Mar 1st, 2026 the market cap of MacroGenics was reported to be:

A$0.17 Billion
by Nasdaq info icon info icon
A$0.17 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$220.09 B 125,572.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.376 T 786,036.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$294.49 B 168,054.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$262.25 B 149,647.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$424.97 B 242,559.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$180.21 B 102,802.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$1.22 B 597.77%๐Ÿ‡บ๐Ÿ‡ธ USA